Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity
Featuring an interview with Dr Erica Mayer, including the following topics:
- Risk Assessment and Genomic Assays for Hormone Receptor (HR)-Positive, HER2-Negative Localized Breast Cancer (0:00)
- Investigator Survey Results on Risk Assessment and Genomic Assays (20:07)
- Adjuvant CDK4/6 Inhibitors for High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (24:30)
- Investigator Survey Results on Adjuvant CDK4/6 Inhibitors (30:42)
- Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (32:07)
- Investigator Survey Results on Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (37:44)
- Adjuvant Oral Selective Estrogen Receptor Degraders (SERDs) for HR-Positive, HER2-Negative Localized Breast Cancer (39:05)
- Investigator Survey Results on Adjuvant Oral SERDs (43:02)
- Discussion of Questions from the Community (45:00)
You May Also Like

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

Ologies with Alie Ward
Alie Ward

BrainStuff
iHeartPodcasts

Het uur van de waarheid
VRT NWS

A hombros de gigantes
Radio 5

Bigfoot Eyewitness Radio
Vic Cundiff

Created to Reign
Cornwall Alliance for the Stewardship of Creation

Universe Today Podcast
Fraser Cain

John Michael Godier's Event Horizon
John Michael Godier
Community discussion